Psychedelic Breakthroughs

Excitement surrounds Compass Pathways as they lead the charge in developing a potential Psilocybin drug for treating depression and PTSD. With promising research indicating significant benefits for treatment-resistant cases, the future of psychedelics in therapy could be transformative. As the company navigates the IPO landscape, the anticipation for their breakthrough drug continues to grow.